← Back to Colinz Laboratories Ltd Overview
📊Financials📈PE Ratio🥧Shareholding💰Dividend📋Quarterly⚖️Balance Sheet💹P&L🌊Cash Flow
COLINZPharmaceuticals

Colinz Laboratories Ltd — Financial Ratios & Key Metrics

₹44.50
+0.00%
P/E Ratio39.55xIndustry: 31.77x
ROE5.43%Return on equity
ROCE6.72%Return on capital
Debt/Equity0.07Low debt
💎

Valuation & Profitability

P/E Ratio
39.55x
Industry Average P/E
31.77x
Dividend Yield
0.00%
Market Cap
₹18.19 (Cr)
Sales Growth 5Y
-2.81%
Profit Growth 5Y
30.92%
EPS Growth 5Y
30.92%
OPM 5Y Avg
7.65%
📉

Price Returns

1 Month
-4.17%
3 Months
-8.25%
6 Months
-37.67%
1 Year
-29.58%
52W Low
₹36
Current
₹45
52W High
₹88
16% of 52-week range — Near lows
🔬

Technical Indicators

48RSI 14
Neutral
Momentum is balanced — neither overbought nor oversold.
SMA 50
₹52
▼ Price below SMA 50 — Bearish
SMA 200
₹47
▼ Long-term downtrend
Volume Signal
2% of avg
Below average volume — low conviction

Technical indicators are for educational purposes only. Not investment advice.

More on Colinz Laboratories Ltd

OverviewFinancialsPE HistoryShareholdingQuarterlyBalance SheetP&LCash FlowPharmaceuticals StocksScreener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.